Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 11,136 | 10,471 | 8,686 | 8,493 | 9,169 |
| Operating Income | -11,136 | -10,471 | -8,686 | -8,493 | -9,169 |
| Other Income | 360 | 357 | 670 | -183 | -684 |
| Pre-tax Income | -10,776 | -10,114 | -8,016 | -8,676 | -9,853 |
| Net Income Continuous | -10,776 | -10,114 | -8,016 | -8,676 | -9,853 |
| Net Income | $-10,776 | $-10,114 | $-8,016 | $-8,676 | $-9,853 |
| EPS Basic Total Ops | -0.21 | -0.21 | -0.17 | -0.20 | -0.24 |
| EPS Basic Continuous Ops | -0.21 | -0.21 | -0.17 | -0.20 | -0.24 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.17 | -0.20 | -0.24 |
| EPS Diluted Continuous Ops | -0.21 | -0.21 | -0.17 | -0.20 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.21 | -0.18 | -0.20 | -0.24 |
| EBITDA(a) | $-11,071 | $-10,420 | $-8,633 | $-8,442 | $-9,115 |